US 9,808,574 B2
Insertion device
Ofer Yodfat, Maccabim-Reut (IL); Avraham Neta, Misgav (IL); and Illai Gescheit, Misgav (IL)
Assigned to Roche Diabetes Care, Inc., Indianapolis, IN (US)
Filed by Ofer Yodfat, Maccabim-Reut (IL); Avraham Neta, Misgav (IL); and Illai Gescheit, Misgav (IL)
Filed on Jun. 25, 2008, as Appl. No. 12/215,255.
Claims priority of provisional application 60/937,155, filed on Jun. 25, 2007.
Claims priority of provisional application 60/937,214, filed on Jun. 25, 2007.
Claims priority of provisional application 60/937,163, filed on Jun. 25, 2007.
Prior Publication US 2008/0319414 A1, Dec. 25, 2008
Int. Cl. A61M 5/142 (2006.01); A61B 5/00 (2006.01); A61M 5/158 (2006.01); A61M 5/42 (2006.01); A61B 5/145 (2006.01); A61M 5/14 (2006.01)
CPC A61M 5/14248 (2013.01) [A61B 5/6849 (2013.01); A61M 5/158 (2013.01); A61M 5/422 (2013.01); A61B 5/14532 (2013.01); A61M 5/1413 (2013.01); A61M 2005/1426 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/1581 (2013.01); A61M 2005/1585 (2013.01); A61M 2205/362 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/3673 (2013.01)] 21 Claims
OG exemplary drawing
 
1. A subcutaneous insertion apparatus comprising:
a housing configured to receive at least one cartridge unit, the at least one cartridge unit comprising a protective member containing therein at least one subcutaneously insertable element and at least one penetrating member, the housing including:
a first housing opening adapted for at least loading therethrough the at least one cartridge unit into the housing; and
a second housing opening adapted for at least protracting therethrough the at least one insertable element and the at least one penetrating member; and
a displacement mechanism contained within the housing and configured to at least protract the at least one insertable element and the at least one penetrating member through the second housing opening toward the body of the patient for subcutaneous insertion of the at least one insertable element,
wherein the displacement mechanism is configured to be primed for activation prior to the housing receiving the at least one cartridge unit; and
the insertion apparatus is configured to couple to a skin-securable cradle that comprises a tubular protrusion emerging upwardly from the cradle that defines therein a well, the well comprising a plurality of penetration tunnels for directing the subcutaneous insertable element toward a plurality of angles with respect to a plane of a bottom housing opening, and the insertion apparatus is configured to align the subcutaneous insertable element with any of the plurality of penetration tunnels of the well, so as to insert the subcutaneous insertable element through the aligned tunnel.